Delivery Order SPE2DB24D9223-SPE2DB25FKELV
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, valued at $18,238.39, was awarded on August 7, 2025, with an ultimate completion date of August 28, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,132.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract carries an ultimate completion date of September 30, 2025, and was awarded on September 9, 2025, with no set-aside designation applied. DMS Pharmaceutical Group will perform the work at its Park Ridge facility, delivering...
- The Defense Logistics Agency awarded a delivery order valued at $36,122.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's broader contractual relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $18,149.94 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. The award represents a discrete purchase order issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $15,860.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC)...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,753.25 by the Defense Logistics Agency on August 15, 2025, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 8, 2025, and no set-aside designation was applied to this award. This delivery order will be performed at the vendor's facility in...
- The U.S. Department of Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $27,403.64 to DMS Pharmaceutical Group Inc. for the supply of Prolastin C 1,000 mg/20 ml vials. The contract, which carries no set-aside designation, is scheduled for completion by September 23, 2025, and will be fulfilled from the vendor's distribution facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will deliver this...
- The Defense Logistics Agency awarded a delivery order valued at $17,604.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on June 12, 2025, with an ultimate completion date of July 7, 2025, represents a discrete procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,273.77 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical...
- The Defense Logistics Agency awarded a $18,273.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 24, 2025, for the supply of Prolastin C 1,000 mg/20 ml vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKELVDelivery Order
The Defense Logistics Agency (DLA) awarded a $18,132.25 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract was awarded on September 15, 2025, with an ultimate completion date of October 6, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will occur at the vendor's facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's SPE2DB program, valued at $499,999,999 through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide. Prolastin C, an alpha-1 proteinase inhibitor used in treatment for genetic alpha-1 antitrypsin deficiency, represents one of the specialized pharmaceutical products covered under this broader vehicle. As a primary pharmaceutical supplier to the Department of Defense healthcare system, DMS Pharmaceutical Group maintains a robust portfolio of federal contract awards encompassing prescription medications, biologics, vaccines, and specialty pharmaceuticals critical to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.1k | 9/15/25 |